The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - GenesisCare; Telix Pharmaceuticals
Stock and Other Ownership Interests - Telix Pharmaceuticals
Safety, tolerability, and dosimetry of 177Lu-TLX591 with best standard of care in patients with PSMA-expressing metastatic castration-resistant prostate cancer (ProstAct-SELECT).
 
Nat Lenzo
Employment - Telix Pharmaceuticals
Stock and Other Ownership Interests - Clarity Pharmaceuticals (I); Telix Pharmaceuticals (I)
Consulting or Advisory Role - Telix Pharmaceuticals
Research Funding - PI for Clarity Pharmaceuticals PROPELLOR trial; Telix Pharmaceuticals
 
Ken O'Byrne
No Relationships to Disclose
 
Stanley Ngai
No Relationships to Disclose
 
Danielle Meyrick
No Relationships to Disclose
 
Neel Patel
Employment - GlaxoSmithKline; Telix Pharmaceuticals
Stock and Other Ownership Interests - Telix Pharmaceuticals
 
Colin Hayward
Employment - Telix Pharmaceuticals
Stock and Other Ownership Interests - Telix Pharmaceuticals